Literature DB >> 18442865

Modular drug transporters with diphtheria toxin translocation domain form edged holes in lipid membranes.

Yuri V Khramtsov1, Tatyana I Rokitskaya, Andrey A Rosenkranz, Georgiy A Trusov, Nikolay V Gnuchev, Yuri N Antonenko, Alexander S Sobolev.   

Abstract

Modular/chimeric recombinant drugs or drug transporters usually contain a special translocation domain from bacterial toxins, e.g. diphtheria toxin, as a module enabling escape of the chimeric molecules from acidifying endosomes. This approach is limited by the shortage in the knowledge about the precise molecular mechanisms of translocation of diphtheria toxin and the toxin-based chimera across the endosomal membrane and its release into the cytosol. We present experimental data with the modular recombinant drug transporters (MRTs), containing the translocation domain of diphtheria toxin, developed by us earlier, demonstrating that the MRTs interact with lipid membranes (liposomes, free-standing and supported bilayer lipid membranes) and produce defects in them at endosomal pH's which are sufficient for escape of macromolecules: - MRTs induced leakage of calcein-loaded liposomes pH 3-6.5. Large fluctuating conductance states of 2-5 nS are formed in membranes at pH 5.5. Atomic force microscopy revealed two different types of defects in the supported lipid bilayers at pH 5.5: 1) giant pores (50-200 nm diameters) and 2) small depressions/holes (30-50 nm) produced by the MRTs which are inserted into the membranes thus forming the structures described above. The last was shown with the use of cantilever tips modified with anti-MRT antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442865     DOI: 10.1016/j.jconrel.2008.03.011

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  MNT Optimization for Intracellular Delivery of Antibody Fragments.

Authors:  A V Ulasov; Y V Khramtsov; T N Lupanova; A D Tsvetkova; A A Rosenkranz; T A Slastnikova; G P Georgiev; A S Sobolev
Journal:  Dokl Biochem Biophys       Date:  2018-05-19       Impact factor: 0.788

2.  Characterization of new modular nanotransporters with albumin-binding domain.

Authors:  Yu V Khramtsov; A V Ulasov; A D Tsvetkova; A A Rosenkranz; G P Georgiev; A S Sobolev
Journal:  Dokl Biochem Biophys       Date:  2017-04-19       Impact factor: 0.788

Review 3.  Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Michael R Zalutsky; Alexander S Sobolev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

4.  Stabilization of Modular Nanotransporters by Embedding Hemin in Them in a New Strain with Heme Receptor Expression.

Authors:  Yu V Khramtsov; A V Ulasov; A A Rosenkranz; G P Georgiev; A S Sobolev
Journal:  Dokl Biochem Biophys       Date:  2020-04-27       Impact factor: 0.788

5.  Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Pavel V Gulak; Raymond M Schiffelers; Tatiana N Lupanova; Yuri V Khramtsov; Michael R Zalutsky; Alexander S Sobolev
Journal:  Int J Nanomedicine       Date:  2012-02-02

6.  Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Natalia B Morozova; Maria S Vorontsova; Vasiliy M Petriev; Tatiana N Lupanova; Alexey V Ulasov; Michael R Zalutsky; Raisa I Yakubovskaya; Alexander S Sobolev
Journal:  Int J Nanomedicine       Date:  2017-01-10

7.  Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression.

Authors:  Andrey A Rosenkranz; Tatiana A Slastnikova; Tatiana A Karmakova; Maria S Vorontsova; Natalia B Morozova; Vasiliy M Petriev; Alexey S Abrosimov; Yuri V Khramtsov; Tatiana N Lupanova; Alexey V Ulasov; Raisa I Yakubovskaya; Georgii P Georgiev; Alexander S Sobolev
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

Review 8.  Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters.

Authors:  Alexander S Sobolev
Journal:  Front Pharmacol       Date:  2018-08-27       Impact factor: 5.810

Review 9.  Novel modular transporters delivering anticancer drugs and foreign DNA to the nuclei of target cancer cells.

Authors:  A S Sobolev
Journal:  J BUON       Date:  2009-09       Impact factor: 2.533

10.  Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody.

Authors:  Tatiana S Karyagina; Alexey V Ulasov; Tatiana A Slastnikova; Andrey A Rosenkranz; Tatiana N Lupanova; Yuri V Khramtsov; Georgii P Georgiev; Alexander S Sobolev
Journal:  Front Pharmacol       Date:  2020-03-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.